Perfusion Device Keeps Donor Eyes Alive, Bringing Full Transplants Closer
Researchers have built a device that uses perfusion to slow degeneration in removed donor eyes, preserving electrical signals and potentially sight after transplant.
Researchers have built a device that uses perfusion to keep donor eyes from deteriorating after removal, a step that could make whole-eye transplants viable for the first time. Eyes begin to break down the moment they leave the body, and a transplant attempted in recent years failed to restore sight in the recipient. The new device pumps oxygen and nutrients into the removed eye, mimicking what the body normally supplies, and treated eyes appear to hold onto the ability to send electrical signals, which is closely tied to functional vision.
What happened
Transplanting a whole human eye is one of surgery’s stubborn unsolved problems. The procedure is technically demanding, and the organ itself works against the surgeon: eyes start breaking down almost immediately after being removed from a donor. When surgeons carried out a whole-eye transplant in recent years, the transplanted eye did not restore vision in the patient.
Now researchers think they have a practical fix. They built a device that applies a technique called perfusion to freshly removed eyes. Perfusion feeds a removed organ the oxygen and nutrients it would normally receive while still inside a living body, dramatically slowing the degeneration process.
According to the researchers, eyes treated with the device appear to retain the capacity to transmit electrical signals. That matters because those signals are how the eye communicates visual information to the brain. Shannon Tessier at Massachusetts Institute of Technology described the results as “really cool.”
Why it matters
Millions of people live with blindness caused by conditions that damage the eye itself, not the brain or optic nerve. A successful whole-eye transplant could, in theory, address cases where no other treatment works. Until now, the window between organ removal and transplant has been too short and the organ too fragile to make that realistic.
Perfusion is already used to preserve other organs, including hearts and livers, during transport. Applying it to eyes is not a guaranteed path to a working transplant, but it removes one of the biggest obstacles: keeping the eye in good enough condition to have a chance of functioning once it is connected to a new blood supply.
The electrical signal finding is particularly significant. Preserving signal transmission does not prove the eye will see after transplant, but it suggests the cells responsible for vision are still alive and active in a perfused eye, which was not previously achievable.
Our take
This is not a story about a product you can buy or a surgery your hospital offers next month. It is early-stage research, and the gap between “eye retains electrical signals in a lab device” and “patient reads an eye chart after transplant” is enormous.
That said, the perfusion angle is credible. The technique has a solid track record with other organs, so applying it to eyes is a logical extension rather than a speculative leap. The real test will come when surgeons attempt another whole-eye transplant using a perfusion-preserved organ and measure actual visual outcomes.
For now, the takeaway is that a genuine technical barrier, organ degradation after removal, appears to have a plausible solution. That is meaningful progress, even if the finish line is still far away.
What to do about it
If you follow medical technology or run content in the health space, keep an eye (no apology for that) on perfusion research as a category. Here is what is worth tracking:
- Whether researchers publish peer-reviewed results on the electrical signal data from perfused donor eyes.
- Any announcement of a clinical trial involving a whole-eye transplant with a perfusion-preserved organ.
- Shannon Tessier’s lab at MIT, which appears to be a key group in this area.
- Regulatory moves by the FDA around organ preservation devices, which could signal how quickly this moves toward clinical use.
Do not write off whole-eye transplantation as science fiction. The biology is hard, but the engineering is catching up.
Frequently asked questions
Has a whole eye transplant ever been successfully performed on a human?
Surgeons have attempted a whole-eye transplant in recent years, but the transplanted eye was not able to restore vision in the recipient. A fully successful, sight-restoring whole-eye transplant has not yet been achieved.
What is perfusion and how does it help preserve donor eyes?
Perfusion is a technique that supplies a removed organ with oxygen and nutrients, similar to what it receives inside a living body. Applied to donor eyes, it slows degeneration and appears to help the eye retain the ability to transmit electrical signals linked to vision.
Can a transplanted eye restore sight?
No whole-eye transplant has restored vision so far. The new perfusion device is a research step that may improve conditions for a future successful transplant, but clinical proof of restored sight has not been demonstrated.
Why do eyes degenerate so quickly after removal from the body?
Eyes begin breaking down almost immediately after removal because they are cut off from the blood supply that delivers oxygen and nutrients. Without those inputs, cells in the eye deteriorate rapidly, which is the problem the perfusion device is designed to address.